A survey of 100 senior MedTech personnel in UK & Ireland
The global MedTech industry is bouncing back from the Covid-19 pandemic, with Europe playing a leading role in a significant resurgence. MedTechs that were start-ups only a few years ago continue to grow, fuelled by the innovation and entrepreneurialism of their founders and staff.
Yet despite the huge opportunities in data-driven healthcare, it is not enough to have just a great solution. Devices and solutions must integrate with complex health systems and comply with demanding data standards and regulations. Without such data interoperability, uptake by major healthcare providers is unlikely.
To discover more about the data challenges facing MedTechs in the UK and Ireland, we surveyed 100 senior personnel in the industry. The diagnosis is clear: while all companies surveyed say they have interoperability strategies already in place, almost three-quarters (74%) are still struggling to make their data interoperable with today’s healthcare data standards.
Other highlights from the findings include:
- 38% say the inability to achieve cost-effective interoperability is holding them back
- 29% have a data platform that doesn’t work with current health data standards
- 30% of surveyed companies in the UK and 28% in Ireland that already use a data platform say it’s not currently up to the job
The MedTech sector is fast-moving and highly competitive. For a solution to be successful, companies must achieve interoperability with health systems and technologies, and be able to pull data from multiple sources meeting both legacy standards and fast-evolving new requirements. No solution can be an island.